Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-24

Study Completion Date

2019-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized controlled trial for patients with stress urinary incontinence or stress-dominant mixed incontinence. Subjects will be randomized to 8-weeks of home kegel exercises or 8 weeks of pelvic floor muscle exercises using the leva digital pelvic health system that includes visual biofeedback via smartphone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard Exercises for Stress Urinary Incontinence

NCT04508153

Stress Urinary Incontinence

COMPLETED NA

Use of the Leva Incontinence System in Treating Bladder Incontinence.

NCT03536923

Stress Urinary Incontinence

COMPLETED NA

Efficacy of a Non-invasive Pelvic Floor Muscle Trainer for Treatment of Stress Urinary Incontinence

NCT05624645

Stress Urinary Incontinence Urinary Incontinence Pelvic Floor Disorders

COMPLETED NA

Pelvic Floor Muscle Training With Leva System for Urge Incontinence

NCT03923348

Overactive Bladder Urge Urinary Incontinence Mixed Urinary Incontinence

TERMINATED NA

Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence

NCT04027335

Fecal Incontinence

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized controlled trial for patients with stress urinary incontinence or stress-dominant mixed incontinence.Subjects will be randomized to 8-weeks of home kegel exercises or 8 weeks of pelvic floor muscle exercises using the leva digital pelvic health system that includes visual biofeedback via smartphone. Leva subjects will perform guided pelvic floor muscle exercises for 2 1/2 minutes twice daily. Home kegel subjects will perform kegel exercises three times daily. Following 8-weeks of training, subjects will be permitted to continue the exercises or pursue additional therapies as indicated. Subjects randomized to the leva digital health system will be further randomized to receive automated reminders for the remainder of one year, or no additional reminders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Urinary Incontinence Mixed Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Assessments of pelvic floor muscle function accomplished by testing at baseline, 4-weeks (mid-study) and 8-weeks will be performed by blinded assessor

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Leva Arm

Subjects will undergo pelvic floor muscle training using the leva device (a vaginal probe) which provides immediate visual feedback via smartphone regarding the motion of pelvic floor muscles. Subjects will perform exercises 2 1/2 minutes twice daily for 8 weeks. At the beginning of the study, four weeks later, and eight weeks later subjects will undergo pelvic floor muscle testing using the PFDx device and surveys to document response to training. After eight weeks, subjects may pursue any additional treatments they wish, but may continue to use the device. They will be further randomized to receive reminder text messages or no messages over 10 months. Subjects will be asked to complete follow up surveys at 6- and 12-months.

Group Type EXPERIMENTAL

Leva

Intervention Type DEVICE

Subjects randomized to Leva will use a vaginal probe containing motion-based sensors to direct the performance of pelvic muscle exercises.

PFDx

Intervention Type DEVICE

All subjects (in both study arms) will be evaluated using a vaginally placed device that will evaluate pelvic floor motion to document change in pelvic floor muscle function resulting from pelvic floor muscle exercises.

Kegel Arm

Subjects in this arm will perform pelvic floor muscle exercises (Kegels) for the treatment of stress or mixed urinary incontinence. Subjects will be asked to perform exercises three times daily for 8 weeks. At the beginning of the study, four weeks later, and eight weeks later, subjects will undergo pelvic floor muscle testing (using the PFDx device) and surveys to document response to training. After eight weeks, subjects may pursue any additional treatments they wish, but may continue to use the device.

Group Type ACTIVE_COMPARATOR

PFDx

Intervention Type DEVICE

All subjects (in both study arms) will be evaluated using a vaginally placed device that will evaluate pelvic floor motion to document change in pelvic floor muscle function resulting from pelvic floor muscle exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Leva

Subjects randomized to Leva will use a vaginal probe containing motion-based sensors to direct the performance of pelvic muscle exercises.

Intervention Type DEVICE

PFDx

All subjects (in both study arms) will be evaluated using a vaginally placed device that will evaluate pelvic floor motion to document change in pelvic floor muscle function resulting from pelvic floor muscle exercises.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Capable of giving informed consent.
* Self-reported stress-type UI symptoms of \>= three months duration
* Diagnosis of stress predominant urinary incontinence based on MESA stress symptom score greater than MESA urge symptom score (percent of total possible urge score).
* UDI-6 score \>/= 25
* Willing to participate in the 8-week study with follow up at 6-and 12-months, refraining from the pursuit of treatment for Stress Urinary Incontinence using other modalities (i.e. will not wear a pessary, participate in pelvic floor PT or surgery) during the first 8- weeks.

Exclusion Criteria

* Absence of a vagina.
* Age \<18 years.
* Stage 3-4 pelvic organ prolapse (as determined by POP-Q).
* Diagnosis of any neuromuscular disease.
* Non-ambulatory.
* Currently pregnant or \<12 months post-partum.
* \</= 3 months after failed surgery for stress urinary incontinence.
* Previous pelvic floor muscle training (PFMT) within the last 12 months under a supervised therapeutic plan of care.
* Currently taking, or has taken within the last 2 months, medication to treat urinary incontinence.
* Prior augmentation cystoplasty or artificial sphincter.
* Implanted nerve stimulator for urinary symptoms.
* Participation in another clinical study within 30 days of screening.
* Impaired cognitive function.
* Contraindication to the use of a vaginal probe.
* Unable to understand instructions on the use of the leva® Plus Pelvic Digital Health System.
* Unable to actively recruit the pelvic floor muscles to any degree for attempted volitional contraction.

Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No